Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Novavax, Inc (NASDAQ:NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat.
Novavax，Inc.纳斯达克周三开盘上涨10%，但截至记者发稿时，该股几乎回吐了全部涨幅，交易基本持平。
The pharmaceutical company's NVX-CoV2373 COVID-19 vaccine was recommended for Emergency Use Authorization for individuals 18 years of age and older by a committee of independent U.S. Food and Drug Administration vaccine advisors. The vaccine will be the fourth available COVID-19 vaccine available in the U.S.
该制药公司的NVX-CoV2373新冠肺炎疫苗被一个独立的委员会推荐为18岁及以上个人的紧急使用授权美国食品和药物管理局疫苗顾问。该疫苗将是美国可用的第四种新冠肺炎疫苗。
The news didn't impress Bank of America analyst Alec Stranahan, who maintained an Underperform rating on the stock with a $35 price target. Stranahan doesn't believe the demand for vaccines outweighs the current supply.
这消息没有给人留下深刻的印象美国银行分析员亚历克·斯特拉汉，他对该股维持了不佳的评级，目标价为35美元。斯特拉汉认为，疫苗的需求不会超过目前的供应。
The brief rally in Novavax appeared likely from a technical perspective, regardless of the news, because the stock has been trading in a downtrend and was due to print a lower high. Although the trend suggests more downside, there are bullish signs on Novavax's chart traders can watch for.
无论有什么消息，从技术角度来看，Novavax的短暂反弹似乎都是可能的，因为该股一直处于下跌趋势，并将创下更低的高点。尽管这一趋势暗示了更多的下行空间，但在Novavax的图表上有看涨迹象，交易员可以密切关注。
Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial.
想要直接分析吗？来BZ Pro休息室找我吧！点击这里免费试用。
The Novavax Chart: Novavax's downtrend began on May 19 and the stock's most recent lower high was printed on June 1 at $57.49 and the most recent lower low was formed at the $41.10 mark on Monday. Wednesday's high-of-day may mark the next lower high within the downtrend, although more candles will need to print for verification.
Novavax图表：Novavax的下跌趋势始于5月19日，该股最近的较低高点是在6月1日打印的57.49美元，最近的较低低点是在周一形成的41.10美元关口。周三的高点可能标志着下跌趋势中的下一个较低高点，尽管还需要打印更多蜡烛来验证。
- Bullish traders will be watching for the double bottom pattern to hold and, perhaps, become recognized, especially if Novavax trades lower to form a triple bottom pattern. The double bottom pattern was printed at the $41.33 on May 12 and Monday and if Novavax can reverse to the upside again at that level it could provide a solid entry point.
- Bullish traders can also take note of the bullish divergence that is occurring on Novavax's chart. Novavax has been trading within the $40 to $63 range since April 7, but the stock's relative strength index has been making a series of higher lows, which indicates Novavax is gaining momentum.
- Bearish traders want to see Novavax continue to reject the eight-day and 21-day exponential moving averages (EMAs), which could continue to guide the stock lower.
- Novavax has resistance above the EMAs at $54.50 and $76.59 and support below at $40.98 and $26.10.
- 看涨的交易员将关注双底格局能否守住，或许会得到认可，特别是如果Novavax交易走低形成三重底格局的话。双底形态在5月12日和周一分别印在41.33美元，如果Novavax能够在该水平再次逆转上行趋势，它可能提供一个坚实的切入点。
- 看涨的交易者也可以注意到Novavax图表上正在发生的看涨背离。自4月7日以来，Novavax的交易价格一直在40美元至63美元的区间内，但该股的相对强弱指数一直在一系列较高的低点，这表明Novavax正在获得动力。
- 看跌的交易员希望看到Novavax继续拒绝八日和21日指数移动均线(EMA)，这可能会继续引导该股走低。
- Novavax在均线上方的阻力位在54.50美元和76.59美元，下方的支撑位在40.98美元和26.10美元。
See Also: How to Read Candlestick Charts for Beginners
另请参阅：如何阅读初学者的烛台图表